Detalhe da pesquisa
1.
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 384(16): 1529-1541, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882206
2.
Management of patients with HER2-positive metastatic breast cancer: is there an optimal sequence of HER2-directed approaches?
Cancer
; 121(1): 17-24, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25056442
3.
The 21-gene recurrence score and locoregional recurrence in breast cancer patients.
Ann Surg Oncol
; 22(4): 1088-94, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25472643
4.
Optimizing Endocrine Therapy for Breast Cancer.
J Natl Compr Canc Netw
; 13(8): e56-64, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26285250
5.
Genomic subtypes in choosing adjuvant therapy for breast cancer.
Oncology (Williston Park)
; 27(3): 204-10, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23687790
6.
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
J Clin Oncol
; 41(24): 4004-4013, 2023 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207300
7.
Targeting angiogenesis in advanced breast cancer.
BioDrugs
; 21(4): 209-14, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17628118
8.
Clinical pharmacology and use of microtubule-targeting agents in cancer therapy.
Methods Mol Med
; 137: 209-34, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18085232
9.
High pathologic complete response in Her2-positive, early-stage breast cancer to a novel nonanthracycline neoadjuvant chemotherapy.
Clin Breast Cancer
; 15(1): 31-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25065563
10.
Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy.
Int J Breast Cancer
; 2015: 147476, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26266050
11.
Adjuvant hormonal therapy for early-stage breast cancer.
Cancer Treat Res
; 141: 63-78, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18274083
12.
Special considerations in early-stage breast cancer patients and survivors.
Obstet Gynecol Clin North Am
; 40(3): 573-82, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24021258
13.
Final results from phase II trial of neoadjuvant docetaxel and capecitabine given sequentially or concurrently for HER2-negative breast cancers.
Clin Breast Cancer
; 13(3): 173-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23332349
14.
Chemoprevention of breast cancer.
Curr Probl Cancer
; 28(4): 201-17, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15318323